Investing Profile

Marcos Milla

InvestorVC
Venture Partner at Samsara BioCapital
Photo of Marcos Milla, Venture Partner at Samsara BioCapital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Samsara BioCapital Venture Partner
$10.0M - $100.0M
$25.0M
5
$310.1M
CompanyStageDateRound SizeTotal Raised
Enlaza Therapeutics
Series AApr 2024$100M
SeedOct 2022$61M
$160M
Co-investors: Stephen Squinto (OrbiMed), Jay Lichter (Avalon Ventures), James N. Topper (Frazier Healthcare Partners)
Tentarix Biotherapeutics
Series BSep 2023$35M
Series AOct 2021$50M
$85M
Co-investors: Allyson Tighe (Amplitude VC), Paul Grayson (Versant Ventures), Jerel Davis (Versant Ventures)
ImmunOs Therapeutics
Series BJun 2022$73M
$99M
Co-investors: Miklos Stanek (BackBone Ventures), Michael Baran (Pfizer Venture Investments), Reinhard Ambros, Daniel Vasella